{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:17:59Z","timestamp":1783581479399,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100009881","name":"JDRF Canada","doi-asserted-by":"crossref","award":["17-2013-312"],"award-info":[{"award-number":["17-2013-312"]}],"id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-015-0318-9","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T13:37:20Z","timestamp":1453729040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort"],"prefix":"10.1186","volume":"15","author":[{"given":"Johnny W.","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif E.","family":"Lovblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devrim","family":"Eldelekli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary A.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narinder","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z. I.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"issue":"6","key":"318_CR1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","volume":"46","author":"SP Laing","year":"2003","unstructured":"Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46(6):760\u20135.","journal-title":"Diabetologia"},{"key":"318_CR2","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/diacare.28.9.2130","volume":"28","author":"G Roglic","year":"2005","unstructured":"Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130\u20135.","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"318_CR3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","volume":"44","author":"NJ Morrish","year":"2001","unstructured":"Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(suppl 2):S14\u201321.","journal-title":"Diabetologia"},{"key":"318_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1475-2840-12-156","volume":"12","author":"O Schnell","year":"2013","unstructured":"Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A. Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013;12:156.","journal-title":"Cardiovasc Diabetol."},{"issue":"9","key":"318_CR5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2105\/AJPH.81.9.1158","volume":"81","author":"SE Moss","year":"1991","unstructured":"Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991;81(9):1158\u201362.","journal-title":"Am J Public Health"},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035\u20138.","journal-title":"JAMA."},{"issue":"3","key":"318_CR7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.diabres.2010.02.009","volume":"88","author":"JC Zgibor","year":"2010","unstructured":"Zgibor JC, Ruppert K, Orchard TJ, Soedamah-Muthu SS, Fuller J, Chaturvedi N, Roberts MS. Development of a Coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in type 1 diabetes risk model. Diabetes Res Clin Pract. 2010;88(3):314\u201321.","journal-title":"Diabetes Res Clin Pract"},{"key":"318_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diacare.27.3.704","volume":"27","author":"CS Fox","year":"2004","unstructured":"Fox CS, Sullivan L, D\u2019Agostino RB Sr, Wilson PW. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham heart study. Diabetes Care. 2004;27:704\u20138.","journal-title":"Diabetes Care"},{"key":"318_CR9","first-page":"CD004816","volume":"1","author":"F Taylor","year":"2011","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Smith GD, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;1:CD004816.","journal-title":"Cochrane Database Syst Rev"},{"key":"318_CR10","doi-asserted-by":"crossref","first-page":"g4356","DOI":"10.1136\/bmj.g4356","volume":"349","author":"S Rabar","year":"2014","unstructured":"Rabar S, Harker M, O\u2019Flynn N, Wierzbicki AS. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ. 2014;349:g4356.","journal-title":"BMJ"},{"issue":"suppl 1","key":"318_CR11","first-page":"S61","volume":"37","author":"J Stone","year":"2013","unstructured":"Stone J, Fitchett D, Grover S, Lewanczuk R, Lin P. Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: vascular protection in people with diabetes. Can J Diabetes. 2013;37(suppl 1):S61\u20138.","journal-title":"Can J Diabetes."},{"issue":"suppl 1","key":"318_CR12","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2337\/dc15-S011","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Cardiovascular disease and risk management. Sec. 8. In standards of medical care in diabetes. Diabetes Care. 2015;38(suppl 1):S49\u201357.","journal-title":"Diabetes Care"},{"issue":"10","key":"318_CR13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-009-0673-0","volume":"65","author":"S Perreault","year":"2009","unstructured":"Perreault S, Dragomir A, Blais L, Lalonde L, White M, Pilon D. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013\u201324.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9374","key":"318_CR14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","volume":"361","author":"R Collins","year":"2003","unstructured":"Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361(9374):2005\u201316.","journal-title":"Lancet"},{"key":"318_CR15","first-page":"SP11","volume":"12","author":"TB Gibson","year":"2006","unstructured":"Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA. Impact of statin copayments on adherence and medical care utilization and expenditures. Am J Manag Care. 2006;12:SP11\u20139.","journal-title":"Am J Manag Care"},{"issue":"18","key":"318_CR16","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","volume":"10","author":"TR Bates","year":"2009","unstructured":"Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother. 2009;10(18):2973\u201385.","journal-title":"Expert Opin Pharmacother"},{"issue":"23","key":"318_CR17","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","volume":"119","author":"PM Ho","year":"2009","unstructured":"Ho PM, Bryson CL, Rumsfeld JS. Medication adherence its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028\u201335.","journal-title":"Circulation"},{"issue":"5","key":"318_CR18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cjca.2012.05.007","volume":"28","author":"M Lemstra","year":"2012","unstructured":"Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol. 2012;28(5):574\u201380.","journal-title":"Can J Cardiol"},{"issue":"1","key":"318_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.18553\/jmcp.2014.20.1.51","volume":"20","author":"JF Slejko","year":"2014","unstructured":"Slejko JF, Ho M, Anderson HD, Nair KV, Sullivan PW, Campbell JD. Adherence to statins in primary prevention: yearly adherence changes and outcomes. J Manag Care Pharm. 2014;20(1):51\u20137.","journal-title":"J Manag Care Pharm."},{"key":"318_CR20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jval.2015.06.002","volume":"18","author":"PK Rannanheimo","year":"2015","unstructured":"Rannanheimo PK, Tiittanen P, Hartikainen J, Helin-Salmivaara A, Huupponen R, Vahtera J, Korhonen MJ. Impact of statin adherence on cardiovascular morbidity and all-cause mortality in the primary prevention of cardiovascular disease: a population-based cohort study in finland. Value Health. 2015;18:896\u2013905.","journal-title":"Value Health."},{"issue":"4","key":"318_CR21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"CA Jackevicius","year":"2002","unstructured":"Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462\u20137.","journal-title":"JAMA"},{"issue":"7","key":"318_CR22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1464-5491.2008.02476.x","volume":"25","author":"LA Donnelly","year":"2008","unstructured":"Donnelly LA, Doney AS, Morris AD, Palmer CN, Donnan PT. Long-term adherence to statin treatment in diabetes. Diabet Med. 2008;25(7):850\u20135.","journal-title":"Diabet Med"},{"issue":"13","key":"318_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-13-26","volume":"24","author":"JC Fruchart","year":"2014","unstructured":"Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, et al. Residual Risk Reduction Initiative (R3i). Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol. 2014;24(13):26.","journal-title":"Cardiovasc Diabetol."},{"issue":"4","key":"318_CR24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/dc10-1675","volume":"34","author":"JK Sun","year":"2011","unstructured":"Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, Strauch CM, Monnier VM, Doria A, Aiello LP, King GL. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist Study. Diabetes Care. 2011;34(4):968\u201374.","journal-title":"Diabetes Care"},{"issue":"11","key":"318_CR25","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","volume":"59","author":"HA Keenan","year":"2010","unstructured":"Keenan HA, Sun JK, Levine J, Doria A, Aiello LP, Eisenbarth G, Bonner-Weir S, King GL. Residual insulin production and pancreatic \u03b2-cell turnover after 50 years of diabetes: joslin medalist study. Diabetes. 2010;59(11):2846\u201353.","journal-title":"Diabetes"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1464-5491.2003.01029.x","volume":"20","author":"SC Bain","year":"2003","unstructured":"Bain SC, Gill GV, Dyer PH, Jones AF, Murphy M, Jones KE, Smyth C, Barnett AH. Characteristics of type 1 diabetes of over 50\u00a0years duration (the golden years cohort). Diabet Med. 2003;20:808\u201311.","journal-title":"Diabet Med"},{"key":"318_CR27","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.diabres.2010.12.007","volume":"91","author":"SL Prior","year":"2011","unstructured":"Prior SL, Jones DA, Gill GV, Bain SC, Stephens JW. Association of the adiponectin rs266729 C\u00a0>\u00a0G variant and coronary heart disease in the low risk \u2018golden years\u2019 type 1 diabetes cohort. Diabetes Res Clin Pract. 2011;91:e71\u20134.","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"318_CR28","first-page":"S61","volume":"37","author":"P McFarlane","year":"2013","unstructured":"McFarlane P, Gilbert R, MacCallum L, Senior P. Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: chronic kidney disease in diabetes. Can J Diabetes. 2013;37(suppl 1):S61\u20138.","journal-title":"Can J Diabetes."},{"issue":"7","key":"318_CR29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"WH Herman","year":"2012","unstructured":"Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, Feldman EL, DCCT\/EDIC Research Group. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications. Diabet Med. 2012;29(7):937\u201344.","journal-title":"Diabet Med"},{"key":"318_CR30","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1136\/bmj.d4891","volume":"343","author":"T Krause","year":"2011","unstructured":"Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:4891.","journal-title":"BMJ"},{"key":"318_CR31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wrigh JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA"},{"issue":"3","key":"318_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","volume":"5","author":"TR Pedersen","year":"2004","unstructured":"Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Py\u00f6r\u00e4l\u00e4 K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H. Scandinavian simvastatin survival study group. randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). 1994. Atheroscler Suppl. 2004;5(3):81\u20137.","journal-title":"Atheroscler Suppl."},{"key":"318_CR33","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","volume":"339","author":"The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group","year":"1998","unstructured":"The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349\u201357.","journal-title":"N Engl J Med"},{"issue":"20","key":"318_CR34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","volume":"279","author":"JR Downs","year":"1998","unstructured":"Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas coronary atherosclerosis prevention study. JAMA. 1998;279(20):1615\u201322.","journal-title":"JAMA"},{"issue":"8","key":"318_CR35","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","volume":"36","author":"S Casagrande","year":"2013","unstructured":"Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The Prevalence of meeting A1C, blood pressure, And LDL goals among people with diabetes, 1988\u20132010. Diabetes Care. 2013;36(8):2271\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"318_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0828-282X(10)70393-7","volume":"26","author":"M Braga","year":"2010","unstructured":"Braga M, Casanova A, Teoh H, Dawson KG, Gerstein HC, Fitchett DH, Harris SB, Honos G, McFarlane PA, Steele A, Ur E, Yale JF, Langer A, Goodman SG, Leiter LA. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol. 2010;26(6):297\u2013302.","journal-title":"Can J Cardiol"},{"issue":"3","key":"318_CR37","first-page":"196","volume":"61","author":"B Crossman","year":"2008","unstructured":"Crossman B, Nguyen A, Slavik V, Allan D. Adherence to Canadian diabetes association clinical practice guidelines for patients attending an outpatient diabetes education Centre. Can J Hosp Pharm. 2008;61(3):196\u2013202.","journal-title":"Can J Hosp Pharm."},{"issue":"6","key":"318_CR38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dme.12409","volume":"31","author":"NR Jones","year":"2014","unstructured":"Jones NR, Fischbacher CM, Guthrie B, Leese G, Lindsay RS, McKnight JA, Pearson D, Philip S, Sattar N, Wild SH, Scottish Diabetes Research Network Epidemiology Group. Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2\u00a0years following diagnosis of diabetes in Scotland, 2006\u20132008. Diabet Med. 2014;31(6):640\u20136.","journal-title":"Diabet Med"},{"issue":"2","key":"318_CR39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jech.2009.091033","volume":"64","author":"A Shroufi","year":"2010","unstructured":"Shroufi A, Powles JW. Evidence-based public health policy and practice: adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins. J of Epidemiol Comm Health. 2010;64(2):109\u201313.","journal-title":"J of Epidemiol Comm Health."},{"issue":"2","key":"318_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diacare.28.2.301","volume":"28","author":"DM Maahs","year":"2005","unstructured":"Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28(2):301\u20136.","journal-title":"Diabetes Care"},{"issue":"25","key":"318_CR41","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study research group","year":"2005","unstructured":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study research group. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. New Engl J Med. 2005;353(25):2643\u201353.","journal-title":"New Engl J Med."},{"issue":"6","key":"318_CR42","doi-asserted-by":"crossref","first-page":"e0130901","DOI":"10.1371\/journal.pone.0130901","volume":"10","author":"H Halava","year":"2015","unstructured":"Halava H, Westerlund H, Korhonen MJ, Pentti J, Kivim\u00e4ki M, Kjeldg\u00e5rd L, Alexanderson K, Vahtera J. Influence of retirement on adherence to statins in the insurance medicine all-sweden total population data base. PLoS One. 2015;10(6):e0130901.","journal-title":"PLoS One"},{"issue":"12","key":"318_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2840-12-78","volume":"24","author":"A Kautzky-Willer","year":"2013","unstructured":"Kautzky-Willer A, Stich K, Hintersteiner J, Kautzky A, Kamyar MR, Saukel J, Johnson J, Lemmens-Gruber R. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2013;24(12):78.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0318-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T10:20:49Z","timestamp":1600078849000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/15\/1\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0318-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"article-number":"14"}}